Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Science (New York, N.Y.)|August 6, 1993
Metal compounds in therapy and diagnosisM J Abrams, B A Murrer
Advances in Enzyme Regulation|January 1, 1991
Platinum coordination complexes which circumvent cisplatin resistanceK R Harrap, L R Kelland, M Jones, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|May 15, 1995
Bis(acetato)amminedichloro(cyclohexylamine)platinum(IV), an orally active anticancer drugS Neidle, C F Snook, B A Murrer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
The tissue distribution in BALB/c mice of C-14-labeled JM216, an orally active platinum antitumour compoundP I Bates, H L Sharma, B A Murrer, et al.
International Journal of Cancer|September 15, 1995
DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell linesK J Mellish, C F Barnard, B A Murrer, et al.
British Journal of Cancer|February 24, 1998
In vitro circumvention of cisplatin resistance by the novel sterically hindered platinum complex AMD473J Holford, S Y Sharp, B A Murrer, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 1, 1997
The synthesis of 191Pt labelled JM216, an orally active platinum anti-tumour agentP I Bates, H L Sharma, B A Murrer, et al.
Pageof 6